American Journal of Pharmacological Sciences
ISSN (Print): 2327-6711 ISSN (Online): 2327-672X Website: Editor-in-chief: Srinivas NAMMI
Open Access
Journal Browser
American Journal of Pharmacological Sciences. 2018, 6(1), 13-18
DOI: 10.12691/ajps-6-1-3
Open AccessArticle

Estimation of the Kinetic Parameters of the Inhibition of Tyrosinase by an Extract of S. Mombin (Root Bark) and the Investigation of Likely Interactions of Composite Phytochemicals Using Molecular Docking Calculations

Oyasowo O.1, Fadare O.A.2, , Olawuni J.I.1, Adeyanju M.M.3, Kolawole A.O.4 and Obuotor E.M.1

1Department of Biochemistry, Obafemi Awolowo University, Ile-Ife, Nigeria

2Department of Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria

3Department of Biochemistry, Olabisi Onabanjo University, Ago-Iwoye, Nigeria

4Department of Biochemistry, Federal University of Technology, Akure, Nigeria

Pub. Date: August 07, 2018

Cite this paper:
Oyasowo O., Fadare O.A., Olawuni J.I., Adeyanju M.M., Kolawole A.O. and Obuotor E.M.. Estimation of the Kinetic Parameters of the Inhibition of Tyrosinase by an Extract of S. Mombin (Root Bark) and the Investigation of Likely Interactions of Composite Phytochemicals Using Molecular Docking Calculations. American Journal of Pharmacological Sciences. 2018; 6(1):13-18. doi: 10.12691/ajps-6-1-3


The GCMS analysis of the ethyl acetate fraction of crude aqeous methanol extract of the root bark of Spondias mombin revealed the composition of 18 compounds of which two methyl esters of long chain carboxylic acids (methyl palmitate and (E)-9-octadecenoic acid methyl ester) account for 52% of the entire extract both having % peak area of 25.6% and 26.4% respectively. The ethyl acetate fraction of the S. mombin aqeous methanolic extract inhibited tyrosinase from Agaricus bisporus (mushroom) with an IC50 of 1.016 ± 0.003 mg/ml which was 25 fold higher than that of kojic acid which was used as a standard inhibitor of tyrosinase in a control experiment with an IC50 of 0.04 ± 0.006 mg/ml. The interaction between the EtOAc fraction of S. mombin and tyrosinase was investigated through fluorescence quenching studies. The fluorescence emission spectra of tyrosinase were recorded in the range of 300 – 500 nm with the excitation and emission wavelengths of tyrosinase at 290 nm and 345 nm respectively. The Intrinsic fluorescence quenching indicated that the test fraction interacted and quenched the fluorescence intensity of tyrosinase in a concentration dependent manner. Kinetic studies with the extract showed that the test fraction elicited a competitive mode of inhibition for the tyrosinase (from A. bisporus). The 3D structures of the 18 compounds detected as constituents of the fraction from GCMS analysis were generated and prepared for docking using a combination of software packages (ChemDraw Ultra 12.0 and MGL tools v1.5.4) and docked (using autodock vina v.1.1.2) with the 3D, X-ray crystallographic structure of the protein (obtained from the protein databank,, pdb code 2Y9X) in order to estimate their binding affinity and interactions with the protein. The docking calculations revealed that five compounds out of the eighteen had higher binding energy (-5.8 kcal/mol to -7.5 kcal/mol) relative to that of the standard, kojic acid (-5.6 kcal/mol). The compound identified to have the highest binding affinity for the tyrosinase is (E)-4-((4-(2-hydroxybenzamido)phenyl)amino)-4-oxobut-2-enoic acid with a binding energy of -7.5 kcal/mol.

tyrosinase fluorescence quenching molecular docking kinetic studies

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Ahn S.J., Koketsu M., Ishihara H., et al., “Regulation of melanin synthesis by selenium-containing carbohydrates,” Chem. Pharm. Bull., 54; 281-286, 2006.
[2]  Iozumi K., Hoganson G.E., Pennella R., et al., “Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes.” J. Invest. Dermatol., 100; 806-811, 1993.
[3]  Li G., Ju H.K., Chang H.W., et al., “Melanin biosynthesis inhibitors from the bark of Machilus thunbergii.” Biol. Pharm. Bull., 26; 1039-1041, 2003.
[4]  Unver N., Freyschmidt-Paul P., Horster S., et al., “Alterations in the epidermal melanin axis and factor XIIIa melanophages in senile lentigo and ageing skin.” Br. J. Dermatol., 155; 119-128, 2006.
[5]  Brenner M., Hearing V.J., “The protective role of melanin against UV damage in human skin.” Photochem. Photobiol., 84; 539-549, 2008.
[6]  Urabe K., Nakayama J., Hori Y., In Norlund J.J., Boissy R.E., et al. eds. The pigmentary system: physiology and pathophysiology. New York, NY: Oxford University Press; 1998: 909-913.
[7]  Asanuma M., Miyazaki., and Ogawa N., “Dopamine or L-DOPA-induced neurotoxicity; the role of dopamine quinone formation and tyrosinase in a model of parkinson’s disease.” Neurotox Res., 5(3):165-176, 2003.
[8]  Nithitanakool S., Pithayanukul P., Bavovada R., and Saparpakorn P., “Molecular Docking Studies and Anti-Tyrosinase Activity of Thai Mango Seed Kernel Extract,” Molecules, 14(1); 257-265, 2009.
[9]  Pillaiyar T., Manickam M., & Namasivayam V., “Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors,” Journal of Enzyme Inhibition and Medicinal chemistry, 32(1); 403-425, 2017.
[10]  Ajao A.O., Shonukan O. and Femi-Onadeko B., “Antibacterial effect of aqueous and alcohol extracts of Spondias mombin, and Alchornea cordifolia-two local antimicrobial remedies.” International Journal of Crude Drug Research, 23(2): 67-72. 1985.
[11]  Ayoka, A.O., Akomolafe, R.O., Akinsomisoye, O.S., and Ukponmwan O.E., “Medicinal and economic value of Spondias mombin.” African Journal of Biomedical Research, 11(2); 34-37, 2008.
[12]  Elufioye T.O., Obuotor E.M., Agbedahunsi J.M., Adesanya S.A., Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae).” Biologics: Targets and Therapy, 11; 107-114, 2017.
[13]  Ayoka, A.O., Akomolafe, R.O., Iwalewa, E.O. and Ukponmwan, O.E., “Studies on the anxiolytic effect of Spondias mombin L. (Anacardiaceae) extracts.” African Journal of Traditional, Complementary and Alternative medicines, 2(2); 153-165, 2006.
[14]  Ashraf Z., Rafiq M., Seo S.Y., Babar, M.M., and Zaidi N.U.S.S., “Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.” Journal of enzyme inhibition and medicinal chemistry, 30(6); 874-883, 2015.
[15]  Kim D., Park J., Kim J., Han C., Yoon J., Kim N., and Lee C., “Flavonoids as mushroom tyrosinase inhibitors: a fluorescence quenching study.” Journal of agricultural and food chemistry, 54(3); 935-941, 2006.
[16]  Trott O., Olson A.J., “AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading” Journal of Computational Chemistry, 31; 455-461. 2010.